Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 287

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Health economics of insomnia treatments: The return on investment for a good night's sleep

Wickwire, Emerson M., Shaya, Fadia T., Scharf, Steven M.·2016·Sleep Medicine Reviews
DOI 10.1016/j.smrv.2015.11.004
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.smrv.2015.11.004

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Research works printed but not linked: 109

  1. Ford, 1989, Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?, JAMA, 262, 1479, 10.1001/jama.1989.03430110069030 · DOI · Paper page
  2. Ancoli-Israel, 1999, Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey, I Sleep, 22, S347
  3. Roth, 2011, Biol Psychiatry, 69, 592, 10.1016/j.biopsych.2010.10.023 · DOI · Paper page
  4. Alattar, 2007, Sleep problems in primary care: a North Carolina family practice research network (NC-FP-RN) study, J Am Board Fam Med, 20, 365, 10.3122/jabfm.2007.04.060153 · DOI
  5. Kushida, 2000, Symptom-based prevalence of sleep disorders in an adult primary care population, Sleep Breath, 4, 9, 10.1055/s-2000-11530 · DOI
  6. Taylor, 2007, Comorbidity of chronic insomnia with medical problems, Sleep, 30, 213, 10.1093/sleep/30.2.213 · DOI · Paper page
  7. Ishak, 2012, Quality of life in patients suffering from insomnia, Innov Clin Neurosci, 9, 13
  8. Neubauer, 2014, New and emerging pharmacotherapeutic approaches for insomnia, Int Rev Psychiatry, 26, 214, 10.3109/09540261.2014.888990 · DOI
  9. Neubauer, 2015, Suvorexant for sleep-onset insomnia or sleep-maintenance Insomnia, or both, Curr Psychiatry, 14, 19
  10. Morin, 2009, Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial, JAMA, 301, 2005, 10.1001/jama.2009.682 · DOI · Paper page
  11. 2005, NIH State of the science conference statement on manifestations and management of chronic insomnia in adults statement, J Clin Sleep Med, 1, 412, 10.5664/jcsm.26373 · DOI
  12. Hatoum, 1998, Insomnia, health-related quality of life and healthcare resource consumption. A study of managed-care organisation enrollees, Pharmacoeconomics, 14, 629, 10.2165/00019053-199814060-00004 · DOI
  13. Daley, 2009, The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers, Sleep, 32, 55
  14. Sarris, 2011, A systematic review of insomnia and complementary medicine, Sleep Med Rev, 15, 99, 10.1016/j.smrv.2010.04.001 · DOI · Paper page
  15. Manber, 2008, Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia, Sleep, 31, 489, 10.1093/sleep/31.4.489 · DOI · Paper page
  16. Fava, 2011, Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial, J Clin Psychiatry, 72, 914, 10.4088/JCP.09m05571gry · DOI
  17. Fava, 2009, Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder, J Clin Psychopharmacol, 29, 222, 10.1097/JCP.0b013e3181a390ba · DOI
  18. Pollack, 2008, Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder, Arch Gen Psychiatry, 65, 551, 10.1001/archpsyc.65.5.551 · DOI
  19. Talbot, 2014, Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial, Sleep, 37, 327, 10.5665/sleep.3408 · DOI · Paper page
  20. Pollack, 2011, Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial, J Clin Psychiatry, 72, 892, 10.4088/JCP.09m05607gry · DOI
  21. Goforth, 2014, A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain, Sleep, 37, 1053, 10.5665/sleep.3760 · DOI
  22. Arnedt, 2011, Cognitive-behavioral therapy for insomnia in alcohol dependent patients: a randomized controlled pilot trial, Behav Res Ther, 49, 227, 10.1016/j.brat.2011.02.003 · DOI · Paper page
  23. Vandrey, 2011, Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal, Drug Alcohol Depend, 117, 38, 10.1016/j.drugalcdep.2011.01.003 · DOI
  24. Pigeon, 2007, The future of behavioral sleep medicine, J Clin Sleep Med, 3, 73
  25. Martin, 2004, Toward cost-effectiveness analysis in the diagnosis and treatment of insomnia, Sleep Med Rev, 8, 63, 10.1016/j.smrv.2003.08.001 · DOI
  26. Leger, 2010, Societal costs of insomnia, Sleep Med Rev, 14, 379, 10.1016/j.smrv.2010.01.003 · DOI · Paper page
  27. Chilcott, 1996, The socioeconomic impact of insomnia. An overview, Pharmacoeconomics, 10, 1, 10.2165/00019053-199600101-00003 · DOI · Paper page
  28. Stoller, 1994, Economic effects of insomnia, Clin Ther, 16, 873
  29. Walsh, 1999, The direct economic costs of insomnia in the United States for 1995, Sleep, 22, S386
  30. Leger, 1999, The direct costs of insomnia in France, Sleep, 22, S394
  31. Kaufmann, 2013, Insomnia and health services utilization in middle-aged and older adults: results from the Health and Retirement Study, J Gerontol A Biol Sci Med Sci, 68, 1512, 10.1093/gerona/glt050 · DOI
  32. Bramoweth, 2012, Chronic insomnia and health care utilization in young adults, Behav Sleep Med, 10, 106, 10.1080/15402002.2011.587067 · DOI
  33. Bolge, 2010, Burden of chronic sleep maintenance insomnia characterized by nighttime awakenings, Popul Health Manag, 13, 15, 10.1089/pop.2009.0028 · DOI
  34. Anderson, 2014, Healthcare utilization and costs in persons with insomnia in a managed care population, Am J Manag Care, 20
  35. Ozminkowski, 2007, The direct and indirect costs of untreated insomnia in adults in the United States, Sleep, 30, 263, 10.1093/sleep/30.3.263 · DOI · Paper page
  36. Sivertsen, 2006, The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study, Am J Epidemiol, 163, 1018, 10.1093/aje/kwj145 · DOI
  37. Leigh, 1991, Employee and job attributes as predictors of absenteeism in a national sample of workers: the importance of health and dangerous working conditions, Soc Sci Med, 33, 127, 10.1016/0277-9536(91)90173-A · DOI
  38. Lavie, 1981, Sleep habits and sleep disturbances in industrial workers in Israel: main findings and some characteristics of workers complaining of excessive daytime sleepiness, Sleep, 4, 147, 10.1093/sleep/4.2.147 · DOI
  39. Akerstedt, 2007, Predicting long-term sickness absence from sleep and fatigue, J Sleep Res, 16, 341, 10.1111/j.1365-2869.2007.00609.x · DOI
  40. Sivertsen, 2009, Does insomnia predict sick leave? the Hordaland health study, J Psychosom Res, 66, 67, 10.1016/j.jpsychores.2008.06.011 · DOI
  41. Leger, 2006, SISYPHE Study Group. Professional correlates of insomnia, Sleep, 29, 171
  42. Sarsour, 2011, The association between insomnia severity and healthcare and productivity costs in a health plan sample, Sleep, 34, 443, 10.1093/sleep/34.4.443 · DOI
  43. Hajak, 2011, Days-out-of-role associated with insomnia and comorbid conditions in the America Insomnia Survey, Biol Psychiatry, 70, 1063, 10.1016/j.biopsych.2011.08.010 · DOI
  44. Rosekind, 2010, Insomnia risks and costs: health, safety, and quality of life, Am J Manag Care, 16, 617
  45. Bolge, 2009, Association of insomnia with quality of life, work productivity, and activity impairment, Qual Life Res, 18, 415, 10.1007/s11136-009-9462-6 · DOI · Paper page
  46. Daley, 2009, Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents, Sleep Med, 10, 427, 10.1016/j.sleep.2008.04.005 · DOI · Paper page
  47. Kessler, 2011, Insomnia and the performance of US workers: results from the America insomnia survey, Sleep, 34, 1161, 10.5665/SLEEP.1230 · DOI · Paper page
  48. Leger, 2014, Insomnia and accidents: cross-sectional study (EQUINOX) on sleep-related home, work and car accidents in 5293 subjects with insomnia from 10 countries, J Sleep Res, 23, 143, 10.1111/jsr.12104 · DOI
  49. Kessler, 2012, Insomnia, comorbidity, and risk of injury among insured Americans: results from the America Insomnia Survey, Sleep, 35, 825, 10.5665/sleep.1884 · DOI
  50. Shahly, 2012, The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey, Arch Gen Psychiatry, 69, 1054, 10.1001/archgenpsychiatry.2011.2188 · DOI
  51. Avidan, 2005, Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes, J Am Geriatr Soc, 53, 955, 10.1111/j.1532-5415.2005.53304.x · DOI · Paper page
  52. Martin, 2006, Limited validity of minimum data set items on sleep and hypnotic use in predicting falls and hip fracture in nursing home residents, J Am Geriatr Soc, 54, 1150, 10.1111/j.1532-5415.2006.00777.x · DOI
  53. Panneman, 2003, The costs of benzodiazepine-associated hospital-treated fall injuries in the EU: a pharmo study, Drugs Aging, 20, 833, 10.2165/00002512-200320110-00004 · DOI
  54. Kyle, 2014, Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: implications for the clinical management of insomnia disorder, Sleep, 37, 229, 10.5665/sleep.3386 · DOI · Paper page
  55. Botteman, 2009, Health economics of insomnia therapy: implications for policy, Sleep Med, 10, S22, 10.1016/j.sleep.2009.07.001 · DOI
  56. Asche, 2010, The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder, Curr Med Res Opin, 26, 1843, 10.1185/03007995.2010.488037 · DOI
  57. Pollack, 2009, Insomnia-related comorbidities and economic costs among a commercially insured population in the United States, Curr Med Res Opin, 25, 1901, 10.1185/03007990903035505 · DOI
  58. Tian, 2012, Resource utilization and costs associated with insomnia treatment in patients with major depressive disorder, Prim Care Companion CNS Disord, 14
  59. Guyatt, 1993, Measuring health-related quality of life, Ann Intern Med, 118, 622, 10.7326/0003-4819-118-8-199304150-00009 · DOI · Paper page
  60. Kyle, 2010, Insomnia and health-related quality of life, Sleep Med Rev, 14, 69, 10.1016/j.smrv.2009.07.004 · DOI · Paper page
  61. Ishak, 2012, Quality of life in patients suffering from insomnia, Innov Clin Neurosci, 9, 13
  62. Katz, 2002, The relationship between insomnia and health-related quality of life in patients with chronic illness, J Fam Pract, 51, 229
  63. Lindley, 1998, Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer, J Clin Oncol, 16, 1380, 10.1200/JCO.1998.16.4.1380 · DOI · Paper page
  64. Pilowsky, 1985, Sleep disturbance in pain clinic patients, Pain, 23, 27, 10.1016/0304-3959(85)90227-1 · DOI · Paper page
  65. Caap-Ahlgren, 2001, Insomnia and depressive symptoms in patients with Parkinson's disease. Relationship to health-related quality of life. An interview study of patients living at home, Arch Gerontol Geriatr, 32, 23, 10.1016/S0167-4943(00)00087-X · DOI
  66. Iliescu, 2003, Quality of sleep and health-related quality of life in haemodialysis patients, Nephrol Dial Transpl, 18, 126, 10.1093/ndt/18.1.126 · DOI · Paper page
  67. Molnar, 2007, Restless legs syndrome, insomnia, and quality of life after renal transplantation, J Psychosom Res, 63, 591, 10.1016/j.jpsychores.2007.06.007 · DOI
  68. Nokes, 2001, Correlates of sleep quality in persons with HIV disease, J Assoc Nurses AIDS Care, 12, 17, 10.1016/S1055-3290(06)60167-2 · DOI
  69. Krystal, 2008, Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia, Ann Clin Psychiatry, 20, 39, 10.1080/10401230701844661 · DOI
  70. Kyle, 2013, The Glasgow Sleep Impact Index (GSII): a novel patient-centred measure for assessing sleep-related quality of life impairment in insomnia disorder, Sleep Med, 14, 493, 10.1016/j.sleep.2012.10.023 · DOI
  71. Leger, 2005, HD-16: a new quality of life instrument specifically designed for insomnia, Sleep Med, 6, 191, 10.1016/j.sleep.2005.03.013 · DOI
  72. Rombaut, 1990, The quality of life of insomniacs questionnaire (QOLI), Med Sci Res, 18, 845
  73. Hajak, 2002, Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study, Int Clin Psychopharmacol, 17, 9, 10.1097/00004850-200201000-00002 · DOI · Paper page
  74. Baca, 2002, on behalf of Castivil group. Quality of life in insomnia: influence of zolpidem, J Sleep Res, 11, 10
  75. Leger, 1996, Health-related quality of life in patients with insomnia treated with zopiclone, Pharmacoeconomics, 10, 39, 10.2165/00019053-199600101-00007 · DOI
  76. Leger, 1995, Sleep, morning alertness and quality of life in subjects treated with zopiclone and in good sleepers. Study comparing 167 patients and 381 good sleepers, Eur Psychiatry, 10, 99s, 10.1016/0924-9338(96)80089-7 · DOI
  77. Goldenberg, 1994, Zopiclone, sleep and health-related quality of life, Hum Psychopharmacol Clin Exp, 9, 245, 10.1002/hup.470090403 · DOI
  78. Scharf, 2005, A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia, Sleep, 28, 720, 10.1093/sleep/28.6.720 · DOI
  79. Walsh, 2000, Eight weeks of non-nightly use of zolpidem for primary insomnia, Sleep, 23, 1087, 10.1093/sleep/23.8.1h · DOI · Paper page
  80. Soeffing, 2008, Psychological treatment of insomnia in hypnotic-dependant older adults, Sleep Med, 9, 165, 10.1016/j.sleep.2007.02.009 · DOI
  81. Van Houdenhove, 2011, Treating primary insomnia: clinical effectiveness and predictors of outcomes on sleep, daytime function and health-related quality of life, J Clin Psychol Med Settings, 18, 312, 10.1007/s10880-011-9250-7 · DOI · Paper page
  82. Byles, 2003, The problems of sleep for older women: changes in health outcomes, Age Ageing, 32, 154, 10.1093/ageing/32.2.154 · DOI
  83. Dixon, 2006, Impact of cognitive behavior therapy on health-related quality of life among adult hypnotic users with chronic insomnia, Behav Sleep Med, 4, 71, 10.1207/s15402010bsm0402_1 · DOI
  84. Espie, 2007, Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice, Sleep, 30, 574, 10.1093/sleep/30.5.574 · DOI · Paper page
  85. Verbeek, 2006, Cognitive behavioral treatment in clinically referred chronic insomniacs: group versus individual treatment, Behav Sleep Med, 4, 135, 10.1207/s15402010bsm0403_1 · DOI
  86. Thorndike, 2013, A randomized controlled trial of an internet intervention for adults with insomnia: effects on comorbid psychological and fatigue symptoms, J Clin Psychol, 69, 1078, 10.1002/jclp.22032 · DOI
  87. Savard, 2005, Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects, J Clin Oncol, 23, 6083, 10.1200/JCO.2005.09.548 · DOI · Paper page
  88. Quesnel, 2003, Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer, J Consult Clin Psychol, 71, 189, 10.1037/0022-006X.71.1.189 · DOI · Paper page
  89. McCall, 2010, Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression, J Clin Sleep Med, 6, 322, 10.5664/jcsm.27872 · DOI
  90. Shimodera, 2014, Change in quality of life after brief behavioral therapy for insomnia in concurrent depression: analysis of the effects of a randomized controlled trial, J Clin Sleep Med, 10, 433, 10.5664/jcsm.3624 · DOI
  91. Horsman, 2003, The Health Utilities Index (HUI): concepts, measurement properties and applications, Health Qual Life Outcomes, 1, 54, 10.1186/1477-7525-1-54 · DOI
  92. Welch, 2007, Construct validity for the Health Utilities Index in a sleep center, Sleep Breath, 11, 295, 10.1007/s11325-007-0111-4 · DOI
  93. Leger, 2012, Chronic insomnia, quality-of-life, and utility scores: comparison with good sleepers in a cross-sectional international survey, Sleep Med, 13, 43, 10.1016/j.sleep.2011.03.020 · DOI
  94. Botteman, 2007, Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model, CNS Drugs, 21, 319, 10.2165/00023210-200721040-00005 · DOI
  95. Krystal, 2003, Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia, Sleep, 26, 793, 10.1093/sleep/26.7.793 · DOI · Paper page
  96. Nichol, 2001, Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36, Med Decis Mak, 21, 105, 10.1177/02729890122062352 · DOI
  97. Jhaveri, 2007, Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States, Curr Med Res Opin, 23, 1431, 10.1185/030079907X199619 · DOI
  98. Snedecor, 2009, Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia, Sleep, 32, 817, 10.1093/sleep/32.6.817 · DOI
  99. Lerner, 2001, The work limitations questionnaire, Med Care, 39, 72, 10.1097/00005650-200101000-00009 · DOI · Paper page
  100. Bonin, 2014, Psycho-educational CBT-Insomnia workshops in the community. A cost-effectiveness analysis alongside a randomised controlled trial, Behav Res Ther, 55, 40, 10.1016/j.brat.2014.01.005 · DOI
  101. Morin, 2011, The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response, Sleep, 34, 601, 10.1093/sleep/34.5.601 · DOI · Paper page
  102. McCrae, 2014, Impact of brief cognitive behavioral treatment for insomnia on health care utilization and costs, J Clin Sleep Med, 10, 127, 10.5664/jcsm.3436 · DOI
  103. Clark, 1995, A chronic disease score with empirically derived weights, Med Care, 33, 783, 10.1097/00005650-199508000-00004 · DOI · Paper page
  104. Tannenbaum, 2015, Sedative-hypnotic medicines and falls in community-dwelling older adults: a cost-effectiveness (decision-tree) analysis from a US medicare perspective, Drugs Aging, 32, 305, 10.1007/s40266-015-0251-3 · DOI
  105. Stone, 2008, Sleep, insomnia and falls in elderly patients, Sleep Med, 9, S18, 10.1016/S1389-9457(08)70012-1 · DOI
  106. Scott, 2011, Insomnia – treatment pathways, costs and quality of life, Cost Eff Resour Alloc, 9
  107. Snedecor, 2010, Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder, J Ment Health Policy Econ, 13, 27
  108. Hamilton, 1960, A rating scale for depression, J Neurol Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
  109. Watanabe, 2014, Cost-effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: analysis of a randomized controlled trial, Psychiatry Clin Neurosci, 69, 335, 10.1111/pcn.12237 · DOI

Cited by

Metadata

Authors
Wickwire, E. M., Shaya, F. T., & Scharf, S. M.
Venue
Sleep Medicine Reviews
Publisher
Elsevier BV
Published
2016-12
Volume
30
Pages
72-82
ISSN
1087-0792 (ISSN-L)
DOI
10.1016/j.smrv.2015.11.004
OpenAlex
W2180077786
Cited by
287
References
26
FWCI
15.55
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.